2,962
Views
38
CrossRef citations to date
0
Altmetric
Research Article

Analysis of hematologic alterations, immune responses and metallothionein gene expression in Nile tilapia (Oreochromis niloticus) exposed to silver nanoparticles

, &
Pages 909-917 | Received 24 Apr 2016, Accepted 26 Sep 2016, Published online: 14 Dec 2016

Figures & data

Table 1. Oligonucleotide primers used for quantitative real-time RT-PCR (Thummabancha et al. Citation2016).

Figure 1. Relative expression ratios of MT gene in Nile tilapia. (a) Liver. (b) spleen. (c) anterior kidney. Values shown are means ± SD. At each given timepoint, bars with different lettering significantly differ from one another at p < 0.05. N = 3 fish/group/timepoint.

Figure 1. Relative expression ratios of MT gene in Nile tilapia. (a) Liver. (b) spleen. (c) anterior kidney. Values shown are means ± SD. At each given timepoint, bars with different lettering significantly differ from one another at p < 0.05. N = 3 fish/group/timepoint.

Table 2. Hematocrit levels in fish.

Table 3. Red blood cell counts in fish.

Table 4. Total white blood cell levels in fish

Figure 2. Functionality of isolated phagocytes. (a) Phagocytic activity (PA). (b) Phagocytic index (PI). (c) Phagocytic efficiency (PE). Cells (from all peripheral blood leukocytes) were isolated from tilapia exposed to 1 or 100 mg AgNP/kg at 1st, 2nd, 4th, 6th and 8th wpi. Values shown are means ± SD. At each given timepoint, bars with different lettering significantly differ from one another at p < 0.05. N = 3 fish/group/timepoint.

Figure 2. Functionality of isolated phagocytes. (a) Phagocytic activity (PA). (b) Phagocytic index (PI). (c) Phagocytic efficiency (PE). Cells (from all peripheral blood leukocytes) were isolated from tilapia exposed to 1 or 100 mg AgNP/kg at 1st, 2nd, 4th, 6th and 8th wpi. Values shown are means ± SD. At each given timepoint, bars with different lettering significantly differ from one another at p < 0.05. N = 3 fish/group/timepoint.

Figure 3. Antibody titer levels in tilapia immunized with vaccine (FASA) and exposed to various doses of AgNP. Values shown are means ± SD. At each given timepoint, bars with different lettering significantly differ from one another at p < 0.05. N = 3 fish/group/timepoint.

Figure 3. Antibody titer levels in tilapia immunized with vaccine (FASA) and exposed to various doses of AgNP. Values shown are means ± SD. At each given timepoint, bars with different lettering significantly differ from one another at p < 0.05. N = 3 fish/group/timepoint.

Figure 4. Cumulative mortality (%) in tilapia with/without AgNP exposure and then challenged with S. agalactiae. Fish that not exposed to AgNP served as control for infections. Values shown are means ± SD. At given timepoint, bars with different lettering significantly differ from one another at p < 0.05. N = 3 fish/group/timepoint.

Figure 4. Cumulative mortality (%) in tilapia with/without AgNP exposure and then challenged with S. agalactiae. Fish that not exposed to AgNP served as control for infections. Values shown are means ± SD. At given timepoint, bars with different lettering significantly differ from one another at p < 0.05. N = 3 fish/group/timepoint.

Figure 5. Cumulative mortality (%) in FASA-vaccinated tilapia with and without AgNP exposure and then challenged with S. agalactiae. Fish that were not immunized with FASA or then exposed to AgNP served as control for infections. Values shown are means ± SD. At each given timepoint, bars with different lettering significantly differ from one another at p < 0.05. N = 3 fish/group/timepoint.

Figure 5. Cumulative mortality (%) in FASA-vaccinated tilapia with and without AgNP exposure and then challenged with S. agalactiae. Fish that were not immunized with FASA or then exposed to AgNP served as control for infections. Values shown are means ± SD. At each given timepoint, bars with different lettering significantly differ from one another at p < 0.05. N = 3 fish/group/timepoint.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.